Welcome to our dedicated page for Smith & Nephew plc news (Ticker: SNN), a resource for investors and traders seeking the latest updates and insights on Smith & Nephew plc stock.
Smith & Nephew plc, also known as Smith+Nephew, is a leading British multinational medical equipment manufacturing company headquartered in Watford, England. Established in 1856, this pioneering firm excels in designing, manufacturing, and marketing advanced medical devices and technologies. Their core business areas include orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions.
Smith+Nephew's revenue is diversified across three main segments: Orthopedics (41%), Sports Medicine and ENT (30%), and Advanced Wound Therapy (29%). The United States contributes roughly half of the company’s total revenue, with other developed markets accounting for over 30%, and the remaining portion coming from emerging markets. The company operates in more than 100 countries and generated annual sales of $5.2 billion in 2022.
Recently, Smith+Nephew celebrated a significant milestone by receiving 510(k) clearance from the U.S. FDA for the AETOS Shoulder System. This advanced system is designed to enhance surgical experiences through greater intraoperative flexibility and fewer conversion steps and instruments, simplifying the operating room flow. The AETOS Shoulder System is part of the company's expanding Upper Extremity portfolio and complements its market-leading Sports Medicine shoulder repair and biologics solutions.
Another notable achievement includes the standout results of the REGENETEN Bioinductive Implant from a randomized controlled trial. This innovative implant substantially reduced re-tear rates in rotator cuff repairs, showcasing Smith+Nephew's commitment to improving patient outcomes through evidence-based solutions.
Smith+Nephew has also entered into a groundbreaking Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR). This agreement allows for collaborative research across all business units, fostering innovation and enhancing combat casualty care.
Moreover, the company launched the RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US, which is a patient-centric option for treating chronic wounds. This system is designed for easy portability and quiet operation, making it suitable for patients' daily activities.
Smith+Nephew's purpose, 'Life Unlimited,' reflects their mission to help restore people's bodies and self-belief by using technology to enhance living. With 19,000 dedicated employees, the company continues to innovate and improve the quality of life for patients worldwide.
For more information about Smith+Nephew, please visit their official website and follow them on social media platforms such as Twitter, LinkedIn, Instagram, and Facebook.
Smith+Nephew (SNN), a global leader in medical technology, has announced its sponsorship of tennis players at Wimbledon 2024, aiming to spotlight its advanced Sports Medicine solutions. The company offers innovative solutions for common tennis injuries like rotator cuff and meniscus tears. Its REGENETEN Bioinductive Implant for rotator cuff repair has been used in over 100,000 procedures globally, showing significant clinical success. The FAST-FIX Family of meniscal repair solutions boasts a 30-year track record, aiding hundreds of thousands of patients with an 88% success rate in all-inside repairs. Smith+Nephew's sponsorship aligns with its mission to help individuals recover from injuries and return to their favorite activities.
Smith+Nephew announced the launch of CORIOGRAPH Pre-Operative Planning and Modeling Services, enhancing its CORI Surgical System for knee arthroplasty procedures. This innovation aims to provide personalized solutions for surgeons and patients, integrating both image-based and image-free registration options. Dr. Steven Haas, an orthopaedic surgeon, recently completed the first procedures using these services, highlighting their potential to improve surgical efficiency and outcomes. The CORI Surgical System is built on over 15 years of expertise and includes tools like the CORI Digital Tensioner and updated RI.KNEE ROBOTICS 3.0 software.
FAQ
What is the current stock price of Smith & Nephew plc (SNN)?
What is the market cap of Smith & Nephew plc (SNN)?
What does Smith & Nephew specialize in?
Where is Smith & Nephew headquartered?
What are the main revenue segments of Smith & Nephew?
What recent achievement has Smith & Nephew made in orthopedic technology?
How does the REGENETEN Bioinductive Implant benefit patients?
What is the purpose of Smith & Nephew's Master CRADA with the USAISR?
What is unique about the RENASYS EDGE NPWT System?
What is Smith & Nephew's company mission?
How many countries does Smith & Nephew operate in?
How can I learn more about Smith & Nephew?
